Home/S&P 500/Health Care/DHR

DHR — Danaher Corporation

Life Sciences Tools & Services · Health Care

S&P 500 Timeline

1998-11-18Joined S&P 500
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes bioprocessing and discovery and medical businesses, providing a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables for studying the basic building blocks of life, including DNA and RNA. The Diagnostics segment provides clinical instruments, reagents, consumables, software, and services for diagnosing diseases and making treatment decisions. The Environmental and Applied Solutions segment offers products and services that help protect essential resources and maintain the safety of global food and water supplies.

Key Facts

StatusActive
SectorHealth Care
IndustryLife Sciences Tools & Services
Joined1998-11-18
Tenure27 yrs

Industry Peers

ACRLIQVMTDTECHTMOWAT

Sector Peers

AABBVABTALGNAMGNBAXBDXBIIBBMYBSX

Institutional Holdings (13F)

2,209 institutions hold DHR, totaling 876.7M shares ($147.4B) · As of 2026Q1

RankInstitutionSharesValue
1VANGUARD CAPITAL MANAGEMENT LLC92.7M$15.9B
2DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main64.5M$15.5B
3BlackRock, Inc.69.0M$10.4B
4BARCLAYS PLC35.4M$8.0B
5MORGAN STANLEY37.6M$7.0B
6STATE STREET CORP32.8M$5.5B
7FMR LLC22.6M$4.3B
8JPMORGAN CHASE & CO17.7M$3.1B
9VANGUARD PORTFOLIO MANAGEMENT LLC21.9M$2.9B
10WELLINGTON MANAGEMENT GROUP LLP14.8M$2.8B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10